Roche Holding AG EBITDA 2012-2025 | RHHBY

Roche Holding AG EBITDA for the quarter ending December 31, 2025 was $0M, a 0% increase year-over-year.

  • Roche Holding AG 2025 EBITDA was 26.387B, a 37.95% increase from 2024.
  • Roche Holding AG 2024 EBITDA was 19.129B, a 8.94% decline from 2023.
  • Roche Holding AG 2023 EBITDA was 21.007B, a 5.97% decline from 2022.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Roche Holding AG EBITDA 2012-2025 | RHHBY

  • Roche Holding AG 2025 EBITDA was 26.387B, a 37.95% increase from 2024.
  • Roche Holding AG 2024 EBITDA was 19.129B, a 8.94% decline from 2023.
  • Roche Holding AG 2023 EBITDA was 21.007B, a 5.97% decline from 2022.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B